• Username (E-mail)
  • Password
Dow 19,913 0.6%  EStoxx50 3,282 0.3%  Nikkei 18,788 -0.6%  EUR 1.0734 -0.3% 
Nasdaq 5,601 0.9%  FTSE100 7,150 0.0%  Yen 113.7880 1.0%  Oil 55.4 0.0% 
S&P500 2,280 0.7%  DAX 11,595 0.4%  GBP 1.2516 -0.1%  Gold 1,210 -0.8% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

Analyst Opinions for Vertex Pharmaceuticals Inc.

12/14/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
12/05/12
Vertex Pharmaceuticals RBC Capital Markets
11/13/12
Vertex Pharmaceuticals Credit Suisse Group
11/05/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
11/02/12
Vertex Pharmaceuticals UBS AG
11/02/12
Vertex Pharmaceuticals RBC Capital Markets
10/12/12
Vertex Pharmaceuticals RBC Capital Markets
09/13/12
Vertex Pharmaceuticals RBC Capital Markets
08/30/12
Vertex Pharmaceuticals RBC Capital Markets
08/02/12
Vertex Pharmaceuticals Banc of America Securities-Merrill Lynch
08/01/12
Vertex Pharmaceuticals Piper Jaffray & Co.
08/01/12
Vertex Pharmaceuticals Credit Suisse Group
07/31/12
Vertex Pharmaceuticals RBC Capital Markets
07/31/12
Vertex Pharmaceuticals UBS AG
07/27/12
Vertex Pharmaceuticals Fuchsbriefe
07/02/12
Vertex Pharmaceuticals RBC Capital Markets
05/08/12
Vertex Pharmaceuticals Needham & Company, LLC
03/28/12
Vertex Pharmaceuticals UBS AG
02/06/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
12/16/11
Vertex Pharmaceuticals Credit Suisse Group
12/05/11
Vertex Pharmaceuticals Citigroup Corp.
11/22/11
Vertex Pharmaceuticals Citigroup Corp.
11/11/11
Vertex Pharmaceuticals UBS AG
11/08/11
Vertex Pharmaceuticals Robert W. Baird & Co. Incorporated
11/07/11
Vertex Pharmaceuticals RBC Capital Markets
11/03/11
Vertex Pharmaceuticals RBC Capital Markets
10/13/11
Vertex Pharmaceuticals RBC Capital Markets
10/11/11
Vertex Pharmaceuticals Citigroup Corp.
10/06/11
Vertex Pharmaceuticals Citigroup Corp.
10/05/11
Vertex Pharmaceuticals Citigroup Corp.
10/04/11
Vertex Pharmaceuticals RBC Capital Markets
09/07/11
Vertex Pharmaceuticals Citigroup Corp.
08/30/11
Vertex Pharmaceuticals Citigroup Corp.
08/18/11
Vertex Pharmaceuticals William Blair
04/04/11
Vertex Pharmaceuticals RBC Capital Markets
02/25/11
Vertex Pharmaceuticals ThinkEquity Partners LLC
02/24/11
Vertex Pharmaceuticals ThinkEquity Partners LLC
02/24/11
Vertex Pharmaceuticals Goldman Sachs Group Inc.
02/08/11
Vertex Pharmaceuticals Goldman Sachs Group Inc.
12/22/10
Vertex Pharmaceuticals RBC Capital Markets
07/30/10
Vertex Pharmaceuticals Wedbush Morgan Securities Inc.
05/27/10
Vertex Pharmaceuticals Needham & Company, LLC
05/26/10
Vertex Pharmaceuticals Wedbush Morgan Securities Inc.
04/23/10
Vertex Pharmaceuticals Needham & Company, LLC
04/13/10
Vertex Pharmaceuticals JP Morgan Chase & Co.
02/05/10
Vertex Pharmaceuticals Morgan Stanley
12/04/09
Vertex Pharmaceuticals Leerink Swann LLC
12/03/09
Vertex Pharmaceuticals Wedbush Morgan Securities Inc.
11/17/09
Vertex Pharmaceuticals Merriman Curhan Ford & Co
11/03/09
Vertex Pharmaceuticals Goldman Sachs Group Inc.
Page: 1 | 2 | 3

Add or Edit Instrument

Latest Analyst Opinions
01/23/17 TLG IMMOBILIEN Norddeutsche Landesbank (Nord/LB)
01/23/17 ABB JP Morgan Chase & Co.
01/23/17 Zurich Insurance Group JP Morgan Chase & Co.
01/23/17 Apple Bernstein Research
01/23/17 Novo Nordisk A-S (B) JP Morgan Chase & Co.
01/23/17 Sky UBS AG
01/23/17 Vodafone Group UBS AG
01/23/17 BT Group UBS AG
01/23/17 RHÖN-KLINIKUM Independent Research GmbH
01/23/17 Credit Suisse Morgan Stanley
01/23/17 Deutsche Bank Morgan Stanley
01/23/17 Intesa Sanpaolo JP Morgan Chase & Co.
01/23/17 HORNBACH Baumarkt Hauck & Aufhäuser Privatbankiers KGaA
01/23/17 RHÖN-KLINIKUM Commerzbank AG
01/23/17 NORMA Group Oddo Seydler Bank AG
01/23/17 Reckitt Benckiser Group Barclays Capital
01/23/17 Deutsche Bank Commerzbank AG
01/23/17 LOréal Barclays Capital
01/23/17 Diageo Barclays Capital
01/23/17 LVMH Moet Hennessy Louis Vuitton Deutsche Bank AG
01/23/17 Renault UBS AG
01/23/17 Continental UBS AG
01/23/17 Daimler UBS AG
01/23/17 adidas Deutsche Bank AG
01/23/17 AstraZeneca Deutsche Bank AG
01/23/17 CompuGroup Medical Baader Bank
01/23/17 Bechtle Baader Bank
01/23/17 Beiersdorf Barclays Capital
01/23/17 Henkel vz Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 GlaxoSmithKline Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 Orange Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 BNP Paribas Deutsche Bank AG
01/23/17 Société Générale SA Deutsche Bank AG
01/23/17 zooplus Warburg Research
01/23/17 ASML Baader Bank
01/23/17 Novo Nordisk A-S (B) Kepler Cheuvreux
01/23/17 Vonovia Kepler Cheuvreux
01/23/17 AIXTRON Baader Bank
01/23/17 Anheuser-Busch InBev UBS AG
01/23/17 PUMA Deutsche Bank AG
01/23/17 Glencore UBS AG
01/23/17 BT Group UBS AG
01/23/17 Royal Dutch Shell (A) UBS AG
01/23/17 Eni UBS AG
01/23/17 LOréal UBS AG
01/23/17 PUMA JP Morgan Chase & Co.
01/23/17 Novo Nordisk A-S (B) Goldman Sachs Group Inc.
01/23/17 Hapag-Lloyd Aktiengesellschaft Goldman Sachs Group Inc.